165 related articles for article (PubMed ID: 31831780)
1. Caveolin-2 deficiency induces a rapid anti-tumor immune response prior to regression of implanted murine lung carcinoma tumors.
Liu Y; Qi X; Li G; Sowa G
Sci Rep; 2019 Dec; 9(1):18970. PubMed ID: 31831780
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.
Liu M; Tong Z; Ding C; Luo F; Wu S; Wu C; Albeituni S; He L; Hu X; Tieri D; Rouchka EC; Hamada M; Takahashi S; Gibb AA; Kloecker G; Zhang HG; Bousamra M; Hill BG; Zhang X; Yan J
J Clin Invest; 2020 Apr; 130(4):2081-2096. PubMed ID: 31945018
[TBL] [Abstract][Full Text] [Related]
3. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
4. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
[TBL] [Abstract][Full Text] [Related]
5. CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.
Li XY; Das I; Lepletier A; Addala V; Bald T; Stannard K; Barkauskas D; Liu J; Aguilera AR; Takeda K; Braun M; Nakamura K; Jacquelin S; Lane SW; Teng MW; Dougall WC; Smyth MJ
J Clin Invest; 2018 Jun; 128(6):2613-2625. PubMed ID: 29757192
[TBL] [Abstract][Full Text] [Related]
6. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
[TBL] [Abstract][Full Text] [Related]
7. Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.
Dammeijer F; Lievense LA; Kaijen-Lambers ME; van Nimwegen M; Bezemer K; Hegmans JP; van Hall T; Hendriks RW; Aerts JG
Cancer Immunol Res; 2017 Jul; 5(7):535-546. PubMed ID: 28536100
[TBL] [Abstract][Full Text] [Related]
8. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.
Rolny C; Mazzone M; Tugues S; Laoui D; Johansson I; Coulon C; Squadrito ML; Segura I; Li X; Knevels E; Costa S; Vinckier S; Dresselaer T; Åkerud P; De Mol M; Salomäki H; Phillipson M; Wyns S; Larsson E; Buysschaert I; Botling J; Himmelreich U; Van Ginderachter JA; De Palma M; Dewerchin M; Claesson-Welsh L; Carmeliet P
Cancer Cell; 2011 Jan; 19(1):31-44. PubMed ID: 21215706
[TBL] [Abstract][Full Text] [Related]
9. Using macrophage activation to augment immunotherapy of established tumours.
Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
[TBL] [Abstract][Full Text] [Related]
10. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
11. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response.
Ubil E; Caskey L; Holtzhausen A; Hunter D; Story C; Earp HS
J Clin Invest; 2018 Jun; 128(6):2356-2369. PubMed ID: 29708510
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8
Murakami T; Hiroshima Y; Zhang Y; Zhao M; Kiyuna T; Hwang HK; Miyake K; Homma Y; Mori R; Matsuyama R; Chishima T; Ichikawa Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Cell Biochem; 2018 Jan; 119(1):634-639. PubMed ID: 28628234
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation generates T cell-dependent control of myeloma in mice.
Vuckovic S; Minnie SA; Smith D; Gartlan KH; Watkins TS; Markey KA; Mukhopadhyay P; Guillerey C; Kuns RD; Locke KR; Pritchard AL; Johansson PA; Varelias A; Zhang P; Huntington ND; Waddell N; Chesi M; Miles JJ; Smyth MJ; Hill GR
J Clin Invest; 2019 Jan; 129(1):106-121. PubMed ID: 30300141
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-Tumor M1 Macrophages.
Park SM; Do-Thi VA; Lee JO; Lee H; Kim YS
Mol Cells; 2020 May; 43(5):479-490. PubMed ID: 32326670
[TBL] [Abstract][Full Text] [Related]
16. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
[TBL] [Abstract][Full Text] [Related]
17.
Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
Front Immunol; 2019; 10():454. PubMed ID: 30967859
[TBL] [Abstract][Full Text] [Related]
18. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
[TBL] [Abstract][Full Text] [Related]
19. M1
Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
[TBL] [Abstract][Full Text] [Related]
20. Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.
Kato Y; Tabata K; Kimura T; Yachie-Kinoshita A; Ozawa Y; Yamada K; Ito J; Tachino S; Hori Y; Matsuki M; Matsuoka Y; Ghosh S; Kitano H; Nomoto K; Matsui J; Funahashi Y
PLoS One; 2019; 14(2):e0212513. PubMed ID: 30811474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
